Bovine Respiratory Disease Treatment Market By Treatment (Vaccines, Antibiotics, Immunomodulators), By Disease, By Distribution Cannel - Growth, Future Prospects And Competitive Analysis 2017 – 2025

The purpose of this research study titled "Bovine Respiratory Disease Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bovine respiratory disease treatment market. This report presents and analyses the major trends prevalent in the global market for bovine respiratory disease treatment, as well as the market's size and forecast.

This report categorizes the global bovine respiratory disease treatment market in terms of treatment type, disease type, distribution channel, and geographical distribution. Based on treatment types, the global bovine respiratory disease treatment market is categorized into vaccines, antibiotics, immunomodulators, and others. Pneumonia, upper respiratory tract infections, and diphtheria are the major disease types considered when bovine respiratory drugs are administered. In terms of distribution channels, this market is categorized into hospitals, clinics, research institutions, and others. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global bovine respiratory disease treatment market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • EU 7
  • CIS
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Asia-Pacific region
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectional presented in terms of disease type, treatment type, distribution channel, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global bovine respiratory disease treatment market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the industrial rubber goods market. The key players profiled in this report are Bayer AG, Boehringer Ingelheim GmbH, Bimeda, Ceva, Elanco, Merck & Co., Inc., Merial, Virbac Group, Vetoquinol, and Zoetis Services LLC.

The global bovine respiratory disease treatment market is studied for the following segments:

  • Treatment Type 
  • Vaccine
  • Antibiotics
  • Immunomodulators
  • Others
  • Disease Type
  • Pneumonia
  • Upper Respiratory Tract Infections
  • Diphtheria
  • Distribution Channel    
  • Hospitals
  • Clinics
  • Research Institutions
  • Others

Vaccines form the largest treatment type for bovine respiratory treatment. Cattle farms have the highest demand for drugs to treat bovine respiratory disease. In such a form of animal husbandry, disease prevention has a critical status for ensuring overall cattle health and, consequently, operational output. Among the disease types, upper respiratory tract infections have the largest prevalence in cattle. Because of the high prevalence of such infections, the demand for drugs for upper respiratory tract infections is highest in emerging markets such as Latin America and Asia Pacific. Hospitals form the largest distribution channel for bovine respiratory disease drugs. Local farmers and breeders often enter into long-term alliances with veterinary hospitals to meet their periodic needs for vaccination and regular check-ups of their cattle. Clinics, on the other hand, have a considerable yet rapidly progressing status in the market. The proliferation of drug administration from clinics is observed to be highest in regions where the veterinary healthcare system is not yet fully established Geographically, the global bovine respiratory diseases treatment market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

Among the considered regional markets, North America currently dominates the global bovine respiratory disease treatment market, followed by Europe. The maturity of the veterinary healthcare market in North America and Western Europe significantly contributes to the dominance of these regions. Other factors contributing to the success of the North American and European markets are the existence of a well-structured animal husbandry industry and the ready availability of the most advanced veterinary healthcare services and drugs. The Asia Pacific market is anticipated to progress at the fastest growth rate during the forecast period. The growth of the Asia Pacific market is majorly attributed to the rapidly increasing demand for animal protein foods and processed meat, the substantial proliferation of animal husbandry businesses, and the evolution of veterinary healthcare infrastructure in the region. Market players have also intensified their efforts toward increasing their footprints in untapped emerging markets in order to gain profitability and maintain a competitive edge.

The detailed regional classification of the global bovine respiratory disease treatment market is as follows:

  • North America (U.S. and Canada)
  • Europe (EU 7, CIS, and Other European Countries)
  • Asia-Pacific (China, India, and the Rest of Asia-Pacific)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)

Frequently Asked Questions:

The market for Bovine Respiratory Disease Treatment Market is expected to reach XX Mn in 2025.

The Bovine Respiratory Disease Treatment Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted to 2017-2025.

The base year of this report is 2016.

Bayer AG,Boehringer Ingelheim GmbH,Bimeda,Ceva,Elanco are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  May 2017
Category:  Pharmaceuticals
Report ID:   58464
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support